(Total Views: 79)
Posted On: 03/30/2021 10:42:41 AM
Post# of 35732
$CURR CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline
https://finance.yahoo.com/news/cure-pharmaceu...00116.html
https://finance.yahoo.com/news/cure-pharmaceu...00116.html
(0)
(0)
Scroll down for more posts ▼